Skip to main content

Harnessing microbiology to tackle global challenges

Centre for Microbial Interactions logo

Dr Naiara Beraza

Group Leader

Research themes:
Microbial Community Interactions
Contact details:
naiara.beraza@quadram.ac.uk
Part of

Biography

My expertise lies in studying the mechanisms that drive the progression of liver disease, with a particular focus on the innate immune response. In my lab, our current research explores the role of the intestine and its microbiome in preserving liver health and influencing disease development.

In 2004, I obtained my PhD at the University of Navarra. My interest at that time was to elucidate the mechanisms underlying liver regeneration and the role of IL-6 family of cytokines in this process.

After receiving a post-doctoral grant in 2004, I moved to Germany to conduct research at the Medical School of the University of Hannover and later at the University Hospital in Aachen. My work focused on the role of IKK complex subunits in regulating NF-kB activation and their impact on the liver’s responses during regeneration, ischemia-reperfusion, non-alcoholic steatohepatitis, and carcinogenesis. I also contributed to defining the role of NK cells in the development of fatty liver disease.

In 2009, I relocated to Spain, joining CICbioGUNE as a Ramon y Cajal Fellow. My research during this period expanded to explore how the innate immune system influences liver disease progression. Additionally, I began investigating how metabolic regulators control liver function and the body’s response to tissue damage. One key finding was that SIRT1, a crucial metabolic regulator, plays a central role in liver regeneration by tightly modulating bile acid homeostasis. I also undertook research on cholestatic liver disease, revealing the involvement of methyltransferases and histone deacetylases in the progression of this chronic condition.

In 2015, I joined the Institute of Food Research, now part of the Quadram Institute, where I established my own research group. My team’s focus is on identifying the molecular mechanisms that regulate the gut-microbiome-liver axis, with the goal of promoting lifelong health and preventing liver disease.